Tradestie Institutional Equity Comparison Engine

SILO vs MAIA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MAIA Overall Edge

MAIA Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to MAIA Biotechnology, Inc. (MAIA) driven by superior Valuation, Growth & Margin while SILO counters with relative strength in Momentum & Technical. Fundamentally, SILO trades at N/M Forward P/E with -8250.5% operating margin (+0.0% YoY revenue) versus MAIA at 1.2x Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, SILO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MAIA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner MAIA
SILO N/M vs MAIA 1.2x Fwd P/E
Growth & Margin Winner MAIA
Op Margin -8250.5% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner SILO
1Y +332.9% vs +20.6% ยท 52W Pos 19% vs 10%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
SILO NASDAQ
Silo Pharma, Inc. Common Stock
Pharmaceutical Preparations
$1.71
-9.04% 1D
Market Cap $4.1M
1M Return +44.92%
1Y Return +332.91%
Forward P/E N/M
Unified AI Score
29.9 / 100 SELL
Tech 50.0 Fund 31.0 Flow 50.0 Mom 50.0
MAIA NYSE American
MAIA Biotechnology, Inc.
Pharmaceutical Preparations
$1.11
-2.63% 1D
Market Cap $68.5M
1M Return -1.77%
1Y Return +20.65%
Forward P/E 1.2x
Unified AI Score
37.6 / 100 SELL
Tech 40.0 Fund 38.0 Flow 50.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SILO +332.91% MAIA +20.65% Spread: +312.26 pp (SILO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SILO TTM Op. Margin: -8250.5% MAIA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SILO vs MAIA. Trailing 12-month operating profitability (SILO -8250.5% vs MAIA 0.0%) and valuation multiples (SILO N/M vs MAIA 1.2x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SILO (2) vs MAIA (6)
Institutional Metric SILO MAIA Criterion Row Winner
Market Capitalization Scale $4.1M $68.5M Larger Scale MAIA
Trailing P/E Ratio Valuation N/M 1.2x Lower Multiple MAIA
Forward P/E Ratio Valuation N/M 1.2x Lower Multiple MAIA
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability -8250.5% 0.0% Higher Margin MAIA
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -91.2% -341.5% Higher ROE SILO
52-Week Range Position Momentum 19% ($0โ€“$8) 10% ($1โ€“$3) Stronger Trend SILO
Beta / 30D Volatility Risk Regime -6.73ฮฒ ยท 123% Vol 1.65ฮฒ ยท 108% Vol Lower Realized Risk MAIA
Unified Institutional Score Composite Signal 29.9 / 100 (SELL) 37.6 / 100 (SELL) Higher Composite MAIA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SILO vs MAIA Buy Guide
SILO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SILO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MAIA UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live MAIA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SILO nor MAIA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.